Venus Remedies Limited Total Assets

Latest as of September 2025: Rs7.68 Billion INR ≈ $83.07 Million USD

Venus Remedies Limited total assets. Based on the latest financial reports, Venus Remedies Limited (VENUSREM) holds total assets worth Rs7.68 Billion INR (≈ $83.07 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Venus Remedies Limited (VENUSREM) total market value for the company's overall valuation and market capitalisation.

Total Assets of Venus Remedies Limited (2006–2025)

Total assets of Venus Remedies Limited from 2006 to 2025. This chart illustrates how Venus Remedies Limited's total assets have evolved over time, based on quarterly financial data. See current stock price of Venus Remedies Limited for real-time trading data and today's change.

Venus Remedies Limited - Asset Composition Analysis

Venus Remedies Limited Total Assets Breakdown (March 2025)

Venus Remedies Limited total assets breakdown as of March 2025. Venus Remedies Limited's total assets of Rs7.68 Billion consist of 63.1% current assets and 36.9% non-current assets.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs575.20 Million	11.2%
Accounts Receivable	Rs1.12 Billion	15.7%
Inventory	Rs1.00 Billion	14.0%
Property, Plant & Equipment	Rs1.51 Billion	21.1%
Intangible Assets	Rs1.05 Billion	14.6%
Goodwill	Rs0.00	0.0%

Asset Composition Trend (2006–2025)

This chart illustrates how Venus Remedies Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Venus Remedies Limited (VENUSREM) liquidity to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Venus Remedies Limited's current assets represent 63.1% of total assets in 2025, an increase from 43.5% in 2006.
Cash Position: Cash and equivalents constituted 11.2% of total assets in 2025, up from 2.1% in 2006.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 14.0% of total assets, a decrease from 18.0% in 2006.
Asset Diversification: The largest asset category is property, plant & equipment at 21.1% of total assets.

Venus Remedies Limited Competitors by Total Assets

Key competitors of Venus Remedies Limited based on total assets are shown below.

Company	Country	Total Assets
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	China	CN¥9.54 Billion
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	China	CN¥6.44 Billion
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	China	CN¥1.54 Billion
Renhe Pharmacy Co Ltd SHE:000650	China	CN¥7.93 Billion
Bide Pharmatech Co. Ltd. A SHG:688073	China	CN¥2.54 Billion
Jianmin Pharmaceutical Group Co Ltd SHG:600976	China	CN¥4.69 Billion
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	China	CN¥2.26 Billion
Shenzhen Neptunus Bioengineering Co Ltd SHE:000078	China	CN¥25.73 Billion

Venus Remedies Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	3.40	3.87	1.53
Quick Ratio	2.65	2.69	0.62
Cash Ratio	0.15	0.31	0.00
Working Capital	Rs3.43 Billion	Rs2.90 Billion	Rs746.30 Million

Venus Remedies Limited - Advanced Valuation Insights

This section examines the relationship between Venus Remedies Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.66
Latest Market Cap to Assets Ratio	0.03
Asset Growth Rate (YoY)	14.2%
Total Assets	Rs7.16 Billion
Market Capitalization	$190.12 Million USD

Valuation Analysis

Below Book Valuation: The market values Venus Remedies Limited's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Venus Remedies Limited's assets grew by 14.2% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Venus Remedies Limited (2006–2025)

The table below shows the annual total assets of Venus Remedies Limited from 2006 to 2025.

Year	Total Assets	Change
2025-03-31	Rs7.16 Billion ≈ $77.40 Million	+14.18%
2024-03-31	Rs6.27 Billion ≈ $67.79 Million	+4.28%
2023-03-31	Rs6.01 Billion ≈ $65.00 Million	+3.67%
2022-03-31	Rs5.80 Billion ≈ $62.71 Million	+4.31%
2021-03-31	Rs5.56 Billion ≈ $60.11 Million	-12.84%
2020-03-31	Rs6.38 Billion ≈ $68.97 Million	-12.98%
2019-03-31	Rs7.33 Billion ≈ $79.25 Million	-2.40%
2018-03-31	Rs7.51 Billion ≈ $81.20 Million	-9.44%
2017-03-31	Rs8.29 Billion ≈ $89.67 Million	-1.63%
2016-03-31	Rs8.43 Billion ≈ $91.15 Million	+0.21%
2015-03-31	Rs8.41 Billion ≈ $90.96 Million	+0.80%
2014-03-31	Rs8.34 Billion ≈ $90.23 Million	+16.28%
2013-03-31	Rs7.18 Billion ≈ $77.60 Million	+25.00%
2012-03-31	Rs5.74 Billion ≈ $62.08 Million	+24.56%
2011-03-31	Rs4.61 Billion ≈ $49.84 Million	+31.64%
2010-03-31	Rs3.50 Billion ≈ $37.86 Million	+18.00%
2009-03-31	Rs2.97 Billion ≈ $32.09 Million	+42.58%
2008-03-31	Rs2.08 Billion ≈ $22.50 Million	+33.76%
2007-03-31	Rs1.56 Billion ≈ $16.82 Million	+149.99%
2006-03-31	Rs622.28 Million ≈ $6.73 Million	--

About Venus Remedies Limited

NSE:VENUSREM India Drug Manufacturers - Specialty & Generic

Market Cap

$190.12 Million

Rs17.58 Billion INR

Market Cap Rank

#16521 Global

#848 in India

Share Price

Rs1315.20

Change (1 day)

+1.13%

52-Week Range

Rs441.75 - Rs1947.00

All Time High

Rs1947.00